Xcout IntelSign inSubscribe

Karo competitors & alternatives

PharmaceuticalsSweden

The 12 closest competitors and alternatives to Karo among pharmaceuticals companies — ranked by similarity to what Karo actually does, not by market-cap band.

12Competitors listed

Subscribe to see Karo’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Karo

Karo Healthcare is a leading pan-European consumer healthcare company headquartered in Stockholm, Sweden. It boasts a portfolio of well-known brands and has recently changed ownership, with funds managed by KKR acquiring the company from EQT.

Karo at a glance

Karo is a pharmaceuticals company headquartered in Sweden. Its most recent funding round, Pre-Series A, raised $6.7M in June 2026. Xcout tracks 5 named people at Karo, including Joseph Bae (Co-Chief Executive Officer).

Karo leadership

  • Joseph BaeCo-Chief Executive Officer
  • Scott NuttallCo-Chief Executive Officer
  • George RobertsCo-founder
  • Henry KravisCo-founder
  • Jerome KohlbergCo-founder

Karo funding rounds

Every round on record:

DateRoundAmountInvestors
Pre-Series A$6.7M1 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Karo competitors

Ranked by semantic similarity — how close each company is to Karo by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Perrigo Company plc0Y5E · PharmaceuticalsDublin, Ireland
62% matchPublic

Similar pharmaceuticals company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Market cap$1.8B
Employees8,100
Perrigo Company plc competitors & alternatives →
CHINARES PHARMA03320 · PharmaceuticalsHong Kong
59% matchPublic

Similar pharmaceuticals company

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.

Market cap$3.6B
Employees85,600
CHINARES PHARMA competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Karo and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Karoand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →